Countries, companies risk billions in race for coronavirus vaccine


Virus vaccine research

In the race to develop a vaccine to end the COVID-19 pandemic, governments, charities and Big Pharma firms are sinking billions of dollars into bets with extraordinarily low odds of success.

They’re fast-tracking the testing and regulatory review of vaccines with no guarantee they will prove effective. They’re building and re-tooling plants for vaccines with slim chances of being approved. They’re placing orders for vaccines that, in the end, are unlikely to be produced.

Play, subscribe and stand a chance to win prizes worth over RM39,000! T&C applies.

Monthly Plan

RM 13.90/month

RM 11.12/month

Billed as RM 11.12 for the 1st month, RM 13.90 thereafter.

Best Value

Annual Plan

RM 12.33/month

RM 9.87/month

Billed as RM 118.40 for the 1st year, RM 148 thereafter.

Follow us on our official WhatsApp channel for breaking news alerts and key updates!
Coronavirus , vaccine , research , companies , governments , risk ,

Next In Business News

Draw of the uniform�
Freight surge reshapes shipping outlook
LTAT set to go global, eyes US tech sector
Cyber threats target trading, vigilance needed
Towards a modern marketplace
Clean tech lessons put to test
Crossing out cross ownership
The multi-trillion dollar question
MFS runs out of solutions
EMs keep their edge

Others Also Read